173 related articles for article (PubMed ID: 1588924)
21. Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase.
Niday E; Wang CS; Alaupovic P
Biochim Biophys Acta; 1980 Mar; 612(1):67-72. PubMed ID: 7362833
[TBL] [Abstract][Full Text] [Related]
22. An inhibitory monoclonal antibody to rabbit brain acetylcholinesterase. Studies on interaction with the enzyme.
Brimijoin S; Mintz KP; Prendergast FG
Mol Pharmacol; 1985 Dec; 28(6):539-45. PubMed ID: 4079910
[TBL] [Abstract][Full Text] [Related]
23. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine.
al-Jafari AA
J Ocul Pharmacol Ther; 1996; 12(4):503-14. PubMed ID: 8951687
[TBL] [Abstract][Full Text] [Related]
24. Binding sites on acetylcholinesterase for reversible ligands and phosphorylating agents. A theoretical model tested on haloxon and phosphostigmine.
Radić Z; Reiner E; Simeon V
Biochem Pharmacol; 1984 Feb; 33(4):671-7. PubMed ID: 6704184
[TBL] [Abstract][Full Text] [Related]
25. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
26. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
Wu CS; Yang JT
Mol Pharmacol; 1989 Jan; 35(1):85-92. PubMed ID: 2913485
[TBL] [Abstract][Full Text] [Related]
27. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
Eastman J; Wilson EJ; Cerveñansky C; Rosenberry TL
J Biol Chem; 1995 Aug; 270(34):19694-701. PubMed ID: 7649979
[TBL] [Abstract][Full Text] [Related]
28. [Acetylcholinesterase. II. Experimental aspects of interaction with reversible effectors under conditions of high ionic strength].
Désiré B; Blanchet G; Definod G; Arnaud R
Biochimie; 1975; 57(11-12):1359-70. PubMed ID: 4154
[TBL] [Abstract][Full Text] [Related]
29. [The inhibition enzymatic hydrolysis of acetylthiocholine by acetylcholinesterase using principal alkaloids isolated from celandine and macleya and their derivatives].
Kuznetsova LP; Nikol'skaia EB; Sochilina EE; Faddeeva MD
Tsitologiia; 2001; 43(11):1046-50. PubMed ID: 11840780
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase.
Kamal MA
Anticancer Res; 1996; 16(6B):3725-30. PubMed ID: 9042248
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase.
Wolfe AD; Chiang PK; Doctor BP; Fryar N; Rhee JP; Saeed M
Mol Pharmacol; 1993 Dec; 44(6):1152-7. PubMed ID: 8264551
[TBL] [Abstract][Full Text] [Related]
33. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
[TBL] [Abstract][Full Text] [Related]
34. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Thomsen T; Kewitz H; Pleul O
J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization.
al-Jafari AA; Kamal MA; Alhomida AS
J Biochem Mol Toxicol; 1998; 12(4):245-51. PubMed ID: 9580877
[TBL] [Abstract][Full Text] [Related]
36. [Effect of environment on allosteric properties of acetylcholinesterase].
Freĭdlin TS; Balashova EK; Rozengart VI; Sherstobitov OE
Biokhimiia; 1977 Sep; 42(9):1626-30. PubMed ID: 20999
[TBL] [Abstract][Full Text] [Related]
37. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
[TBL] [Abstract][Full Text] [Related]
38. Determination of affinity and efficacy of acetylcholinesterase inhibitors using isothermal titration calorimetry.
Draczkowski P; Tomaszuk A; Halczuk P; Strzemski M; Matosiuk D; Jozwiak K
Biochim Biophys Acta; 2016 May; 1860(5):967-974. PubMed ID: 26586471
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human erythrocyte acetylcholinesterase by succinyldicholine.
Lanks KW; Sklar GS
Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):269-75. PubMed ID: 940960
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cholinesterase by epinephrine and norepinephrine.
Mohammed YS; Osman MY
Arzneimittelforschung; 1978; 28(1):16-8. PubMed ID: 580191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
